150 related articles for article (PubMed ID: 36974689)
21. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
22. Sequelae following infantile haemangiomas treated with propranolol.
Baselga E; El Hachem M; Diociaiuti A; Carnevale C; Downey C; Roe E; Mascaro P; Neri I; Leuzzi M; Bernabeu-Wittel J; Monserrat-García MT; Ortiz-Prieto A; Torrelo A; Knopfel N; Vercellino N; Manunza F; Oranges T; Bassi A; Gonzalez-Enseñat MA; Vicente A; Gich I; Puig L
Eur J Dermatol; 2021 Dec; 31(6):785-790. PubMed ID: 35107070
[TBL] [Abstract][Full Text] [Related]
23. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and management of infantile hemangiomas.
Püttgen KB
Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
[TBL] [Abstract][Full Text] [Related]
25. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
[TBL] [Abstract][Full Text] [Related]
26. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
27. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
[TBL] [Abstract][Full Text] [Related]
28. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
29. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
30. Propranolol for infantile hemangioma (PINCH): an open-label trial to assess the efficacy of propranolol for treating infantile hemangiomas and for determining the decline in heart rate to predict response to propranolol.
Sondhi V; Patnaik SK
J Pediatr Hematol Oncol; 2013 Oct; 35(7):493-9. PubMed ID: 23929318
[TBL] [Abstract][Full Text] [Related]
31. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
32. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
[TBL] [Abstract][Full Text] [Related]
33. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas.
Thaivalappil S; Bauman N; Saieg A; Movius E; Brown KJ; Preciado D
JAMA Otolaryngol Head Neck Surg; 2013 Oct; 139(10):1026-31. PubMed ID: 24135743
[TBL] [Abstract][Full Text] [Related]
34. A novel topical nano-propranolol for treatment of infantile hemangiomas.
Chen ZG; Zheng JW; Yuan ML; Zhang L; Yuan WE
Nanomedicine; 2015 Jul; 11(5):1109-15. PubMed ID: 25791814
[TBL] [Abstract][Full Text] [Related]
35. Initial experiences with propranolol treatment of infantile hemangiomas: report of three cases.
Halilbasic A; Hotic N; Husaric E; Rahmanovic E; Halilbasic M; Husaric S
Med Arh; 2011; 65(6):380-2. PubMed ID: 22299307
[TBL] [Abstract][Full Text] [Related]
36. Infantile hemangiomas, complications and treatments.
Cheng CE; Friedlander SF
Semin Cutan Med Surg; 2016 Sep; 35(3):108-16. PubMed ID: 27607318
[TBL] [Abstract][Full Text] [Related]
37. Medical Management of Infantile Hemangiomas: An Update.
Colmant C; Powell J
Paediatr Drugs; 2022 Jan; 24(1):29-43. PubMed ID: 34677814
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of propanolol for treatment of infantile haemangioma.
Andersen IG; Rechnitzer C; Charabi B
Dan Med J; 2014 Feb; 61(2):A4776. PubMed ID: 24495884
[TBL] [Abstract][Full Text] [Related]
39. Treatment of infantile hemangiomas with beta-blockers: a review.
Shah S; Frieden IJ
Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
[TBL] [Abstract][Full Text] [Related]
40. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
